Finance

Beta
Lists
WVE:NASDAQ
Wave Life Sciences Ltd
$5.95
-1.49%
(-0.090) 1D
$5.99
+0.67% (+0.040)
After hours
Closed: Jun 24, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for WVE...
Open
$6.06
High
$6.18
Low
$5.93
Mkt. cap
1.14B
Avg. vol.
3.78M
Volume
44.00
52-wk high
$21.73
52-wk low
$5.02
EPS
-$1.05
Beta
-1.33
Shares outstanding
192.40M
No. of employees
317
Open
$6.06
High
$6.18
Low
$5.93
Mkt. cap
1.14B
Avg. vol.
3.78M
Volume
44.00
52-wk high
$21.73
52-wk low
$5.02
EPS
-$1.05
Beta
-1.33
Shares outstanding
192.40M
No. of employees
317
News stories
From sources across the web
About Wave Life Sciences Ltd
CEO-
Employees317
Founded2012
Headquarters-
SectorPharmaceutical industry
Websitewavelifesciences.com
Analyst Ratings
Based on 15 analysts giving stock ratings to WVE in the past 3 months
Strong Buy
Buy
15
Hold
0
Sell
0
12 month forecast
Based on 15 Wall Street analysts offering 12 month price targets for WVE in the last 3 months.
Highest
Current $5.95
$43.00 (+622.69%)
Average
$23.43 (+293.78%)
Lowest
$13.00 (+118.49%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Salim Syed
Mizuho Securities
Buy
Maintained
$27.00
+353.8%
06/12/2026
Andrew Fein
H.C. Wainwright
Buy
Reiterated
$13.00
+118.5%
06/11/2026
Yun Zhong
Wedbush
Buy
Maintained
$15.00
+152.1%
05/27/2026
Whitney Ijem
Canaccord Genuity
Buy
Maintained
$43.00
+622.7%
05/19/2026
Benjamin Burnett
Wells Fargo
Buy
Reiterated
$14.00
+135.3%
05/20/2026
Danielle Brill
Truist Financial
Buy
Maintained
-
-
05/19/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
$13.00
+118.5%
05/18/2026
Samantha Semenkow
Citi
Buy
Reiterated
$24.00
+303.4%
05/01/2026
Madison Elsaadi
B. Riley Securities
Buy
Reiterated
$31.00
+421%
04/30/2026
Luca Issi
RBC Capital
Buy
Maintained
$15.00
+152.1%
04/28/2026
Alec Stranahan
Bank of America Securities
Buy
Maintained
$19.00
+219.3%
04/28/2026
William Maughan
Clear Street
Buy
Maintained
$36.00
+505%
04/28/2026
Mohit Bansal
Wells Fargo
Buy
Maintained
$13.00
+118.5%
04/01/2026
Tiago Fauth
Raymond James
Buy
Maintained
$13.00
+118.5%
03/27/2026
Roger Song
Jefferies
Buy
Reiterated
$18.00
+202.5%
03/26/2026
Joseph Schwartz
Leerink Partners
Buy
Reiterated
$25.00
+320.2%
03/26/2026
Catherine Novack
JonesTrading
Buy
Maintained
$35.00
+488.2%
03/26/2026
Joon Lee
Truist Financial
Buy
Reiterated
-
-
02/27/2026
Cheng Li
Oppenheimer
Buy
Maintained
$32.00
+437.8%
02/27/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
8.70M
7.61M
17.24M
38.25M
Cost of goods sold
43.47M
45.87M
52.81M
47.44M
Cost of revenue
43.47M
45.87M
52.81M
47.44M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17.99M
18.09M
20.90M
22.10M
Operating expense
17.99M
18.09M
20.90M
22.10M
Total operating expenses
61.46M
63.96M
73.71M
69.54M
Operating income
-52.76M
-56.35M
-56.47M
-31.30M
Other non operating income
-82.00K
324.00K
234.00K
-80.00K
EBT including unusual items
-50.47M
-53.85M
-53.18M
-26.09M
EBT excluding unusual items
-50.47M
-53.85M
-53.18M
-26.09M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-50.47M
-53.85M
-53.18M
-26.09M
Net profit margin
-580.17%
-707.83%
-308.37%
-68.21%
Earnings per share
-0.31
-0.32
-0.30
-0.13
Interest and investment income
2.37M
2.18M
3.05M
5.29M
Interest expense
-
-
-
-
Net interest expenses
2.37M
2.18M
3.05M
5.29M
Depreciation and amortization charges
-
-
-
-
EBITDA
-51.89M
-55.50M
-55.62M
-30.46M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer